1989
DOI: 10.1016/0090-4295(89)90108-8
|View full text |Cite
|
Sign up to set email alerts
|

Patients' choice of treatment in stage D prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
76
0
1

Year Published

1992
1992
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 193 publications
(86 citation statements)
references
References 9 publications
5
76
0
1
Order By: Relevance
“…In summary, there are advantages and disadvantages with both orchidectomy and LHRH analogues. In such a case the preference of the patient is particularly important and a majority seem to prefer LHRH analogues (Cassileth et al, 1989). In this paper we have estimated the difference in economic costs for the two alternatives.…”
Section: Discussionmentioning
confidence: 99%
“…In summary, there are advantages and disadvantages with both orchidectomy and LHRH analogues. In such a case the preference of the patient is particularly important and a majority seem to prefer LHRH analogues (Cassileth et al, 1989). In this paper we have estimated the difference in economic costs for the two alternatives.…”
Section: Discussionmentioning
confidence: 99%
“…The evaluation of quality of life, as perceived by the patient, allows for the assessment of subjective morbidity that, although not always life-threatening, may cause considerable distress. Such minor morbidity is often overlooked during the busy routines of clinical care (Cassileth et al, 1989). The present study revealed that the majority of the studied sample was female and having breast cancer and this comes in accordance with the national prevalence of breast cancer among female as it was the commonest type of cancer among females in Egypt.…”
Section: Discussionmentioning
confidence: 99%
“…Cassileth et al 79,80 used the FLIC and the POMS in 147 men to show longitudinal improvements in HRQOL after medical or surgical androgen ablation, her work suggests that medical these men are quite interested in considering quality of life outcomes when selecting speci®c hormonal therapy. Herr et al 81 86 and with the FACT and SAQ in a smaller study of radiotherapy for advanced disease.…”
Section: Metastatic Prostate Cancermentioning
confidence: 99%